Introduction
In recent decades, an increase in the number of treatment regimens involving immunosuppressant therapies has been associated with a rise in the incidence of invasive nosocomial fungal infections worldwide [1] [2] [3] . Aside from transplant failure or cancer relapse, the primary cause of death for immunocompromised patients is infection, and various species of fungi, particularly Candida and Aspergillus spp., play a major role [4] . The saprophytic filamentous fungus Aspergillus fumigatus is abundant in the environment, and the most common cause of invasive fungal infection in immunocompromised patients [5, 6] . Typically found feeding on decaying organic matter, it plays a crucial role in the recycling of carbon and nitrogen [7, 8] . Aspergillus fumigatus spores, called conidia, are ubiquitous and thus inhaled on a daily basis [9] . Conidia are usually cleared efficiently from the lungs by the innate immune system, but in specific cases they may germinate and cause infection [10] . Infection is most often pulmonary, but infections of the bronchi, sinus, and dissemination to the brain and other organs are also common. Susceptibility to invasive infection is closely linked to the immune status of the host; individuals at highest risk are those with hematological malignancies, particularly acute leukemia, and transplant patients [7, 11] . Although morbidity and mortality are usually associated with invasive aspergillosis (IA) in immunocompromised patients, an even larger number of patients are affected by chronic or allergic conditions caused by Aspergillus spp. [12] . Occurrence of IA in otherwise immunocompetent patients is atypical, but has been reported following influenza [13, 14] in ICU patients without hematological malignancy [15] and in otherwise healthy individuals [16, 17] . Aspergillus fumigatus conidia are small enough to reach the lower airways and are readily internalized by alveolar epithelial cells, where they are able to evade host immune cells and to initiate systemic infection [18] . The low sensitivity of current microbiological and histopathological methods, along with a lack of consistency in surveillance and case definition, has made estimation of the incidence of IA in the past difficult and has probably lead to an underestimation of the true disease burden [19, 20] . However, it is generally recognized that the incidence of invasive fungal infections is increasing, with the major contributors shifting from Candida spp. to Aspergillus spp. [19, 21] . Central nervous system aspergillosis is a particularly devastating condition associated with a very poor prognosis and mortality rates of approximately 90% [11, 12, 17, 22, 23] . In addition, IA is the most common cause of death due to lung infection in hematopoietic stem cell transplant (HSCT) patients [23] . A multicenter prospective survey of 23 institutions in the US reported an incidence of invasive fungal infections in HSCT patients of 0.9%-13.2%. IA was the most common condition, with A. fumigatus by far the most prevalent species implicated. Overall 1-year survival rates for all autologous and allogeneic HSCT patients included in the study were 87% and 64%, respectively, but dropped to 25.4% when including only those who contracted aspergillosis [19] . IA is also common in solid organ transplant recipients, with an associated mortality of approximately 22% [12] . In particular, lung transplant recipients exhibit invasive fungal infections in up to 19% of cases, with the majority of infections caused by A. fumigatus [24] [25] [26] .
Despite the availability and widespread use of antifungals active against A. fumigatus for many years, the mortality rate remains unacceptably high. The major drugs approved for the treatment of IA target components of the cell membrane: amphotericin B, and azole antifungals including voriconazole, itraconazole, posaconazole, and more recently, isavuconazole [27] . Amphotericin B is associated with severe side effects, the most notable being severe kidney and liver toxicity, and has been largely superseded by the azole antifungals, although these are also often associated with significant side effects [28, 29] . Current aspergillosis management guidelines from the Infectious Diseases Society of America recommend voriconazole for primary therapy in almost all cases, and posaconazole for prophylaxis [12] . The last 15 years or so have seen an alarming increase in the incidence of azole-resistant A. fumigatus strains that appear to have originated both in the environment-due to the widespread use of azole antifungals in agriculture-and in the clinic. Azole resistance is a major cause of treatment failure [30] [31] [32] [33] [34] . In addition, as the incidence of Aspergillus infection increases and species identification methods advance, more related species are added to the list that cause disease. These have differing antifungal susceptibilities and have been associated with negative clinical outcomes, highlighting the need for improved diagnostic protocols and a broader range of antifungal options [6, 35] . Expanding our basic knowledge of the essential biological processes of this important fungal pathogen is crucial to further advances in medical treatment, and the development of new antifungal drugs with novel targets. One process that presents as a therapeutic target for many diseases is DNA replication and repair.
Proliferating cell nuclear antigen (PCNA) tethers proteins to DNA in cellular processes including DNA replication, DNA repair, and cell cycle control [36] . It is a member of the sliding clamp family of proteins, found in all three domains of life. Despite a lack of sequence homology between them [37] , all sliding clamps share a pseudo sixfold symmetry arising from six structurally similar domains [38, 39] , and have a high level of structural conservation. In archaea and eukaryotes, the sliding clamp is trimeric [37, 39, 40] . PCNA subunits from different species are able to interact to form a trimer; the PCNA subunit from Saccharomyces pombe is able to interact with both Drosophila melanogaster and human PCNA subunits, suggesting that interactions between PCNA subunits, and important residues in the interaction interface, are evolutionarily conserved [41] . PCNA alone has no intrinsic enzymatic activity but functions by fully encircling DNA and sliding freely. Through this topological interaction it is able to control and coordinate the access of proteins to DNA, particularly at the DNA replication fork. PCNA has been described as a 'tool belt', referring to its ability to interact with numerous and varied proteins [42, 43] . These proteins are interchangeable, allowing for the 'belt' to hold different 'tools' depending on its current role within the cell. The majority of proteins that interact with PCNA contain a PCNA-interacting protein (PIP)-box peptide motif [36] which binds a hydrophobic cavity present on each monomer in the trimeric ring and forms an antiparallel b-sheet with the interdomain connector loop (IDCL) of PCNA. This allows for the binding of up to three such proteins to PCNA at one time [44] . This hydrophobic PIP-box-binding pocket is present in all eukaryotic sliding clamps; a comparable pocket is also present in bacterial sliding clamps, although there are significant differences in the pockets and binding peptides between eukaryotes and bacteria [45] . The PIP-box was first defined by Warbrick et al., using a yeast two-hybrid screen followed by alanine scanning to identify key residues involved in the interaction of the tumor-suppressor protein p21 with PCNA, and its ability to inhibit SV40 DNA replication. It has been suggested that drugs based on the PIP-box of p21, either as derivatives or peptide mimetics, could have therapeutic uses in down-regulating DNA replication [41, 44] . Small molecules that act as competitive inhibitors of the PCNA-PIP-box interaction have also been identified and proposed as novel anticancer therapeutics [46] . In addition, small molecules [47] [48] [49] , natural compound derivatives [50] , peptides [51] , peptide mimetics [45, 52] , and cyclic peptides [53] that target the function of the bacterial sliding clamp have all been presented as novel antimicrobials. Despite its integral role in cell growth and survival, PCNA has not yet been investigated as a target for novel antifungal drugs.
Here we present the first crystal structure of a sliding clamp from a pathogenic fungus. We have solved the X-ray crystal structure of PCNA from A. fumigatus (AfumPCNA) to 2.6 A resolution. The structure reveals a trimeric ring-shaped fold similar to other eukaryotic sliding clamps. Interestingly, the overall structure is more similar to the human sliding clamp than that from Saccharomyces cerevisiae (yPCNA). Fluorescence polarization experiments with AfumPCNA and the PIP-box from human p21 demonstrate a K d of 3 lM, providing evidence that AfumPCNA interacts with proteins at the replication fork though a conserved PIPbox mechanism similar to the human system, rather than the prokaryotic systems which do not employ use of the PIP-box system for protein-protein interactions. We have employed molecular dynamics simulations with AfumPCNA and the human p21 PIP-box to better understand the interactions. This revealed that the secondary structure of the PIP-box motif is similar in its interactions with AfumPCNA as with hPCNA. However, differences in the 3 10 helix interaction cavity and the IDCL as well as a decreased ability to form a betastrand conformation are likely to contribute to the lower affinity of p21 for AfumPCNA rather than hPCNA.
Results

Identification of PCNA from Aspergillus fumigatus
The A. fumigatus protein sequence was identified using the Aspergillus Genome Database and confirmed by means of multiple sequence alignment with PCNA from other species, as shown in Fig. 1 . Analysis of the amino acid sequence of PCNA from several different sequences, as shown in Table 1 , reveals that PCNA from A. fumigatus is most similar to A. thaliana (56.9%) and D. melanogaster (56.6%), followed very closely by human PCNA (53.9%). It is interesting to note that, in terms of PCNA sequence, the fungus A. fumigatus is more closely related to the higher order eukaryotes than to the yeast S. cerevisiae (49.6%). Previous studies have shown evolutionary drift of PCNA between the yeast and pathogenic fungi such as AfumPCNA. In eukaryotic species, the N-and Cterminal domains of each subunit are connected via an extended loop (residues 118 to 134) known as the interdomain connector loop (IDCL), which is necessary for interaction with the PIP-box-containing peptides [44] . Evolutionary drift among the PCNA molecules of Fungi is perhaps most notable in the IDCL. Zamir et al. [54] compared the IDCL of PCNA from numerous different fungal species and found that variation in just 4 of the 12 IDCL residues analyzed appeared to allow segregation of the different species into two distinct groups, as indicated in Fig. 1 . Chimera-based protein-protein binding experiments in which the IDCL of fungal species were interchanged among the PCNA molecules and affinity for PIP-boxcontaining proteins was measured, demonstrated that the IDCLs of the two groups of fungi could not be interchanged without significant loss of affinity. IDCL sequences from Group 1 fungal species (including S. cerevisiae) were incompatible with IDCL sequences from Group II species (including A. fumigatus) suggesting large evolutionary drift among the fungal species. However, to date no structural information has been available to explain these differences.
X-ray crystal structure of PCNA from Aspergillus fumigatus
To gain a better understanding of AfumPCNA structure and mechanism, AfumPCNA was purified and crystallized in space group P2 1 . The AfumPCNA structure was solved to a resolution of 2.6
A by means of molecular replacement. Data processing and [54] ; nonpolar residues are yellow (GAST), polar residues are magenta (NQH), hydrophobic residues are green (CVILPFYMW), negatively charged residues are red (DE), positively charged residues are blue (KR). a-helices and b-sheets are labeled as they were described for the structure of Saccharomyces cerevisiae PCNA [37] . The IDCL is labeled as defined by Gulbis et al. [44] . The four residues within the IDCL identified by Zamir et al. [54] as segregating fungal species into two distinct groups are marked above by asterisks. The IDCL from Pyrococcus furiosus does not clearly belong to either group, as indicated. refinement statistics can be found in Table 2 and a reduced model bias stereo figure of representative electron density can be seen in Fig. 2 . The asymmetric unit is composed of three subunits that form a ringshaped trimer that is representative of DNA sliding clamps from other species (Fig. 3) . Subunits of the trimer show high structural similarity, with RMSD values between subunits ranging from 0.89 A to 0.97 A (calculated over 254 Ca atoms) and total surface areas of 12375 A 2 , 12297 A 2 , and 12446 A 2 , giving an average surface area per subunit of 12373 A 2 . Subunits are composed of four a-helices and 18 b-strands arranged into two domains of nearly identical topology, connected by an IDCL (Fig. 3A) . Each domain consists of two adjacent a-helices covered on one side by two antiparallel b-sheets of four or five strands each. Each b-sheet is continuous with the b-sheet of the adjacent domain, such that six, nine-stranded b-sheets surround the trimeric ring: three cross the domain interface within each subunit and three cross the interface between each subunit (Fig. 3B ). The AfumPCNA trimer therefore has a pseudo sixfold rotational symmetry, with the axis of symmetry running through the center of the ring. The subunits pack to form the trimer leaving a central cavity of approximately 30 A-a diameter which would allow nonspecific interactions with DNA.
Atomic interactions of the AfumPCNA subunit interface
Proliferating cell nuclear antigen oligomerizes via an interface that is conserved among all three subunitsubunit interfaces (Figs 3B and 4). The subunitsubunit interfaces involve the interaction of bI1 and aB1 of the N-terminal domain with bD2 and aA2 of the C-terminal domain. The peripheral b-strands of each domain (bI1 and bD2) form an antiparallel bsheet such that the b-sheet is continuous across the subunit interface. For the following discussion, we refer to the interface between subunits A and C, unless otherwise specified.
The interface surface area is 687.2 A 2 ; similar to the corresponding interfaces of both hPCNA and yPCNA (697.6 A 2 and 654.1 A 2 , respectively), and involving 11 hydrogen bonds (Fig. 4A ) and one salt bridge (Fig. 4B ). Eight hydrogen bonds between peptide backbone atoms of residues 109 to 117 (bI1) and 175 to 183 (bD2) have distances ranging from 2.28 A to 3. 40 A, and define the antiparallel b-sheet (Fig. 4A ). The remaining three hydrogen bonds are weak (distance > 3. 6 A) and are between Lys77 (NZ) and Ala153 (O), Thr108 (N) and Gln193 (OE1), and Asp115 (OD2) and Ser177 (OG). Arg110, contained in bI1, forms a salt bridge with Glu143 from aA2 (Fig. 4B) . The core of the interface is hydrophobic, centered around Tyr114, and is composed of aB1 residues Val78 and Ala81, bI1 residues Tyr114 and Ile116, aA2 residues Leu151 and Leu154, and bD2 residues Ile175 and Val180 (Fig. 4B) . The subunit interface is highly conserved among species, with comparisons to hPCNA and yPCNA revealing very similar surface areas and interacting residues. All of the hydrophobic residues at the interface core are conserved in human and yeast PCNA, and each interface involves a similar number of hydrogen bonds. The most conspicuous nonconservative substitution is at position 153 of aA2, which is an alanine, histidine, or glutamine in AfumPCNA, hPCNA, and yPCNA, respectively. However, this substitution for bulkier residues in both hPCNA and yPCNA appears to have very little effect on the conformation of other interface residues, but may contribute to a slightly larger interaction surface. The only other significant nonconservative substitution at the subunit interface is a glutamine residue in AfumPCNA (Gln83), which is glycine in hPCNA. This permits the side chain of Arg146, which points to solvent in AfumPCNA (Fig. 4B) , to contact aB1 of the opposing subunit of hPCNA, forming a hydrogen bond with Lys80 (O) (2.97 A). The hPCNA interface includes a salt bridge at the end of the b-strand, involving Lys117 and Glu174, which is absent in both AfumPCNA and yPCNA. Lys117 is conserved in fungal PCNA, but residue 174 is an aspartate residue, which lacks the conformational flexibility required to form an electrostatic interaction with Lys117. The salt bridge between residues 110 and 143 is conserved in AfumPCNA, with the variation that 110 is an arginine rather that a lysine. In yPCNA, Arg110 also forms a salt bridge, but partners with Asp150 rather than Glu143. Interestingly, both Glu143 and Asp150 are conserved and in similar positions in both fungal PCNA structures, suggesting that Arg110 may be able to form a salt bridge with either of these residues. This is confirmed in AfumPCNA upon inspection of the interface between subunits B and C, where indeed an Arg110-Asp150 salt bridge is present, rather than the Arg110-Glu143 salt bridge of the interface between subunits A and C. Furthermore, at the remaining interface (A-B), the side chain of Arg110 is disordered in the electron density, consistent with conformational flexibility at this position. In contrast, the shorter side chain of Lys110 of hPCNA precludes it from forming a salt bridge with Asp150, limiting interaction to Glu143.
Comparison of AfumPCNA to the yeast and human PCNA
AfumPCNA shows high overall structural similarity to both the human and yeast PCNA crystal structures (Fig. 5) , with average RMSD values across all subunits of 1.51 A and 1.53 A, respectively. Despite this, variation in the sequence of the IDCL results in structural changes that may affect interactions with binding partners. Interestingly, the IDCL of AfumPCNA showed more similarity to the human IDCL rather than the yeast IDCL, implying the AfumPCNA surface may interact with interacting partners by means of a human type PIP-box. The IDCL (residues 118-134) stretches across the outside of seven of the nine strands of the core b-sheet in each subunit (Fig. 6A) . It is stabilized by a number of interactions with both backbone atoms and side chains protruding from the underlying sheet, including hydrogen bonds between Met119 (N) and Gly69 (O) (2.94 A), Gln123 (NE2) and Asp29 (OD2) (2.70 A), and Leu126 (O) and Gln38 (NE2) (3.32 A). The hydroxyl group of Tyr133 also forms two separate water-mediated hydrogen bonds with Pro234 (O) and Try249 (OH). In addition, Ile128 packs against hydrophobic residues Leu47 and Tyr249, and Tyr133 sits in a hydrophobic pocket formed by Cys228, Val233, Leu236, and Tyr249.
These interactions are conserved in hPCNA, with the notable exception of Gln123. A valine is present at this position of the IDCL in hPCNA, precluding any hydrogen bonding interaction with Asp29. This aspartate residue has been shown to be involved in binding p21 (and other PIP-box peptides with antiparallel bstrand interaction) [44, 55] . Therefore, the sequestering of this hydrogen bond acceptor by Gln123 in AfumPCNA may result in differences in binding specificity and affinity for PIP-box-containing peptides. This difference at position 123 is accompanied by the most evident conformational difference in the IDCL PCNA subunits are depicted in wire format. AfumPCNA is depicted in green (5TUP), hPCNA is depicted in magenta (PDB: 1AXC), and yPCNA is depicted in yellow (PDB: 1PLQ) [37, 44] .
between human and AfumPCNA; relative to Val123 of unliganded hPCNA (PDB: 1W60) [56] , Gln123(Ca) is shifted 4.14 A toward the surface of PCNA and results in a concomitant shift of adjacent residues Asp122 and Glu124 in the same direction (Fig. 6B) .
Inspection of the IDCL from S. cerevisiae PCNA (yPCNA) [37] reveals conformational differences with AfumPCNA (Fig. 6C ). These differences are due to substitutions at His125 and Pro129, two of the four IDCL residue positions that have been used to separate fungal species into two separate evolutionary families (Fig. 1) [54] . However, this region of the yPCNA structure is involved in a number of crystal contacts, which may also contribute to conformational differences in the IDCL. Interestingly, despite the presence of a hydrophobic residue at position Ala123, similar to hPCNA, the position of the IDCL in this region (122 to 124) is more similar to that of AfumPCNA, which contains a glutamine residue at this position (Gln123), as shown in Fig. 6C . Phe125 of yPCNA participates in hydrophobic interactions that have a similar effect on the position of IDCL residues 122 to 124 as the hydrogen bond between the side chains of Gln123 and Asp29 of AfumPCNA. The side chain of Phe125 packs onto the underlying b-sheet via hydrophobic interaction with Ile36 (Ala36 in AfumPCNA), drawing residues 124 to 127 of the IDCL an average of~1.1 A closer to the underlying b-sheet (Fig. 6C) . Phe125 of yPCNA partially occupies the space of Asp29 of both AfumPCNA and hPCNA. This is reflected by the conformation of the side chain of Gln29 of yPCNA, which is shifted~3. 8 A away from the IDCL backbone relative to Asp29 of AfumPCNA, potentially precluding it from acting as a hydrogen-bonding partner for PIP-box-containing peptides. The proline at position 129 in AfumPCNA is Glu129 in yPCNA (Fig. 6C ). This substitution induces a different conformation of the IDCL and markedly alters the position of this residue, allowing it to pack~3.7
A closer to the underlying b-sheet, facilitated by an additional weak hydrogen bond between Glu129 (OE1) and Gln247 (NE2) (3.5 A). This increased flexibility also allows Glu130 to occupy the space of Gln131 in hPCNA, which has been shown to form a hydrogen bond with the Tyr151 side chain hydroxyl group of the p21 peptide [44] . AfumPCNA contains a Thr (Thr131) at this position, a considerably shorter side chain which would require extension of PCNA toward the PIP-box for hydrogen bond formation as compared to the human structure. Proliferating cell nuclear antigen residues (AfumPCNA residue numbers) Met40, Val45, Leu47, Leu126, Ile128, Pro129, Tyr133, Pro234, Tyr249, Ala251, and Pro252 form a hydrophobic pocket that is 'plugged' by the conserved 3 10 helix of the PIP-box. This interaction has been shown to be essential for high-affinity binding of PIP-box-containing peptides [55] . Strikingly, these residues are 100% conserved between hPCNA and AfumPCNA highlighting the conserved nature of this interaction. Comparison of these with the hydrophobic pocket of yPCNA reveals only minor differences, with the only nonconserved substitution being position 129 in the IDCL, as previously mentioned.
Proliferating cell nuclear antigen residues of the C terminus that have been shown to interact with PIPbox peptides include Ala252, Pro253, and Ile255 of hPCNA and Ala251, Pro252, Lys253, and Phe254 of yPCNA [37, 44] . These are conserved in AfumPCNA, suggesting their importance in mediating PCNA-PIP interactions across fungi and mammals. The six Cterminal residues of hPCNA (256 to 261) are disordered in the PCNA:p21-peptide structure. This includes four charged residues which have been suggested to closely associate with the charged residues at the N terminus of the p21 peptide via poorly ordered ionic interactions. The final four residues of AfumPCNA and yPCNA (both 255 to 258) are undefined in the electron density of these structures and include three charged residues, one aspartate and two glutamine residues, suggesting the conservation of this poorly ordered ionic interaction with binding peptides.
AfumPCNA binds p21 peptide with high affinity
To determine if the AfumPCNA interacts with its partners by means of a PIP-box, we determined the affinity of AfumPCNA for a peptide derived from the cyclin-dependent kinase inhibitor protein p21, previously shown to have the highest known affinity for hPCNA [55] . AfumPCNA binding to a canonical human p21 PIP-box motif was determined by incubating FITC-labeled p21 peptide (N-139 GRKRRQTSM TDFYHSKRRLIFS 160-C) with increasing concentrations of AfumPCNA, and measuring the changes in fluorescence polarization. Figure 7 contains the doseresponse curves for the fluorescence binding. A K d value of 3.1 AE 0.1 lM was determined in PBS using similar conditions to Bozza et al. [57] (Fig. 7B) . These authors determined the affinity of hPCNA to the same peptide in these conditions to be 342 nM. Thus, using similar buffer conditions, the p21 interaction for hPCNA is only 10-fold higher in affinity than the interaction with AfumPCNA. In experiments using Tris buffer (Fig. 7A) , the K d was determined to be 1.0 AE 0.1 lM, indicating that removal of salt strengthens the AfumPCNA/p21 interaction. Electrostatic contacts play a role in hPCNA/p21 complex formation, with salt bridges stabilizing the intermolecular b-sheet (hPCNA Asp29 to p21 Arg154, and hPCNA residues Asp122 and Glu124, to p21 Arg155). These hPCNA residues are conserved in AfumPCNA suggesting the intermolecular electrostatic interactions may be maintained, consistent with the FP data.
Deciphering the interaction of p21 with AfumPCNA by molecular dynamics simulation Given our finding that AfumPCNA interacts with the human p21 peptide with high affinity, we performed molecular dynamics simulations to better define the interactions of AfumPCNA with p21 as well as identify the structural basis for the lower affinity interaction with AfumPCNA versus hPCNA. The molecular dynamics simulation was carried out for a total of 50 ns using the AfumPCNA trimer bound to one p21 peptide per subunit. The simulation was stable over the entire time frame as indicated by the RMSD versus time (plotted by secondary structure) depicted in Fig. 8 , and the overall structural trajectory is shown in Fig. 9 . Two movies of the simulation can be found in the Supporting Information section (Movies S1 and S2).
The molecular dynamics simulation revealed that, although the core binding mode of the p21 peptide to PCNA is largely conserved between human and A. fumigatus, a number of differences are present that may contribute to a lower peptide-protein affinity for the A. fumigatus protein. The interaction of p21 with AfumPCNA, much like with hPCNA, can be conceptually divided into interactions of the p21 N terminus, 3 10 helix, and C terminus, the latter of which forms an antiparallel b-sheet with the IDCL of PCNA.
The interaction of the p21 peptide N-terminal residues with the AfumPCNA C terminus was maintained throughout the simulation. Similar to the interactions of p21 with hPCNA, interactions of the N terminus of p21 include a system of hydrogen bonds: a hydrogen bond from p21 Arg143 main chain oxygen atom to Ile255 main chain nitrogen atom and from Gln144 side chain to Ser44 main chain oxygen atom (Fig. 10A) . Unlike the p21 interaction with hPCNA, the side chain of Thr145 does not make a hydrogen bond with AfumPCNA and is instead rotated away from the surface of AfumPCNA making no intermolecular contacts by means of the side chain atoms.
The p21 3 10 helix that plugs a hydrophobic pocket on PCNA was stable throughout the duration of the simulation, reflecting the high conservation of residues that form the pocket (including residues Met40, Val45, Leu47, Leu126, Ile128, Pro129, Tyr133, Pro234, Tyr249, Ala251, and Pro252). Tyr151 is one of the key residues for high-affinity interaction of p21 with hPCNA [58] , due to the side chain hydroxyl proton forming a hydrogen bond to the side chain nitrogen atom of Gln131. This interaction was predicted to be lost in AfumPCNA, due to the substitution of Gln for Thr at this position (Thr131 of AfumPCNA). The simulations showed this held true for two of the three peptide-PCNA interactions, but interestingly, a hydrogen bond between Thr131 (side chain hydroxyl) and p21 peptide Tyr151 (side chain hydroxyl) is present in the remaining peptide interaction, but requires Tyr151 to shift approximately 2.7
A toward the core of the protein. Of the three p21 peptides bound to the PCNA trimer, the peptide which forms the hydrogen bond between Thr131 and Tyr151 also adheres to a wellformed antiparallel b-strand, while the two peptides with unstable b-strand formation are correlated with a loss of hydrogen bonding capacity between these residues (Fig. 10B) . From this it can be deduced that at least part of the lower affinity of p21 for AfumPCNA can be attributed to the lessened ability of p21 to hydrogen bond with AfumPCNA residue Thr131, which is intricately linked to the b-strand conformation of the peptide. In addition, AfumPCNA contains a larger and less hydrophobic surface cavity (124 A 3 in hPCNA/p21 versus 235 A 3 in AfumPCNA/p21) capable of promoting interaction with the 3 10 helix (Fig. 10C,D) ; both of these effects can partly be attributed to the presence of Thr131 in the AfumPCNA structure rather than Gln131 as seen in the hPCNA structure.
The antiparallel b-sheet formed between the p21 peptide C terminus and residues 121-127 of the AfumPCNA IDCL is maintained throughout the simulation for one of the three peptides, partially maintained for another, but has completely dissociated in the case of the remaining peptide (Figs 9 and 10B) . The formation of the b-strand conformation of p21 in the AfumPCNA-bound simulation only occurs with significant rearrangement of the IDCL as compared to the human p21-bound IDCL. The disruption of this interaction is consistent with the observation that Asp123 of the IDCL sequesters the electrostatic interaction to Arg156 in the AfumPCNA crystal structure, precluding the formation of hydrogen bonds to Asp29 from Arg156 of p21 that aid in anchoring the C-terminal half of the peptide to the surface of hPCNA ( Fig. 10E) . Furthermore, His125 of AfumPCNA obstructs b-sheet by formation of a favorable side chain hydrogen bond with the His152 side chain of p21, forcing the peptide in a conformation that is too distant from the surface of AfumPCNA to form the tight hydrogen bonds of a b-sheet as seen in the human structure (Fig. 10E) .
It is interesting to note that, while the interaction between the central 3 10 -helical plug and the AfumPCNA hydrophobic pocket is very stable, the polar interactions between the N-terminal and C-terminal peptide residues and the PCNA C terminus and IDCL, respectively, appear to be mutually exclusive. This is shown by the observation that the loss of intermolecular hydrogen bonding at the C-terminal half of the p21 peptide is accompanied by an increase in the number of hydrogen bonds between the N terminus of the peptide and C terminus of AfumPCNA (Fig. 11C) . In fact, the only peptide for which the conformation of the peptide's N terminus and 3 10 helix (residues 143 to 151) is almost identical to that of the hPCNA-p21 peptide structure is the one that has completely lost the b-sheet interaction at the C-terminal end of the peptide. On the other hand, extensive hydrogen bonding involving the C-terminal region of the peptide is accompanied by a decrease in hydrogen bonding at the N terminus of the peptide (Fig. 11A,B) . Regarding the peptide for which the b-strand in the C-terminal region of the peptide is well maintained, the 3 10 helix is forced into a more a-helical conformation by interaction with Thr131; a peptide conformation which favors C-terminal b-strand formation, but disfavors interactions between the N-terminal region and the C terminus of AfumPCNA.
Discussion
Here we present the first crystal structure of PCNA from A. fumigatus as well as the first crystal structure of PCNA from a pathogenic fungus. Interestingly, the structure of the AfumPCNA is more structurally related to human PCNA than the previously reported S. cerevisiae PCNA. Furthermore, we also demonstrated that AfumPCNA interacts with high affinity with a human PIP-box, implying that PCNA-interacting proteins from the pathogen A. fumigatus are likely to interact with AfumPCNA by means of a conserved PIP-box similar to that of the human sequence. Given that p21 interacts with AfumPCNA with 10-fold lower affinity than its human counterpart, we performed molecular dynamics simulations to uncover fundamental structural differences in the AfumPCNA surface that can account for these differences in affinity. Our MD revealed differences in the IDCL of AfumPCNA that likely contribute to this difference in affinity, including residues Asp29, His125, Asp123, and Thr131.
Previous studies focusing on human PCNA have suggested that a key factor for determining the affinity of a protein for PCNA is the primary sequence of its PIP-box [55, 59] . Therefore, further investigation into native partners of A. fumigatus PCNA, with a focus on their PIP-box sequences, could uncover determinants of high-affinity binding. It has also been suggested that, evolutionarily speaking, natural PCNA-interacting proteins are not optimized for high affinity, but rather that affinity is finely tuned to allow for rapid and appropriate exchange of partners to allow the cell to adapt promptly to changing environmental conditions [55, 60] . This affords the possibility that artificial PIP-box sequences could be designed that have a greater affinity for PCNA than the highest affinity native PIP-box-containing proteins. Indeed, using the p21 PIP-box sequence to [44] bound to p21 (magenta) (PDB: 1AXC). (E) Interactions of the C terminus of p21 (magenta) with AfumPCNA (green).
guide the design of high-affinity peptide mimetics that target hPCNA for the treatment of cancer is the subject of ongoing investigation. In the same way, we expect that the details of the PCNA-peptide interaction interface presented in the current study will be useful for guiding the synthesis of high-affinity peptides which could, in turn, guide the design of stable, high-affinity peptide mimetics that bind tightly to AfumPCNA, halting DNA replication, thereby preventing fungal cell growth. In addition, the differences between the peptide interaction surfaces of hPCNA and AfumPCNA highlighted here may afford specificity of antifungal peptides toward the fungal PCNA over its human homolog. 
Materials and methods
Protein expression and purification
The AfumPCNA coding sequence was PCR amplified from A. fumigatus strain af293 cDNA using primers (a) 5 0 -CCC GGGCATATGTTGGAAGCACGACTAG-3 0 and (b) 5 0 -GG GCCCGGATCCTTACTCCTCATCTCCGATC-3 0 and cloned into the pMCSG19 vector using BamHI and NdeI restriction sites. Sequencing revealed that the sequence coding for AfumPCNA included 117 extra nucleotides at the 5 0 end when compared to the sequence deposited in the NCBI database (Accession XM_745146) [61] but was identical to the ORF sequence available at www.aspergillusgenome.org (afu1g04900) (accessed 23 May 2016), indicating an error in the original annotation. AfumPCNA was overexpressed in Escherichia coli BL21(DE3) shake-flask culture by the addition of 0.5 mM IPTG when the culture reached log-phase, and incubated at 16°C for approximately 18 h. Cell pellets were resuspended in 20 mM Tris pH 7.5, 20 mM NaCl, 0.5 mM EDTA, 2 mM DTT, and stored at À80°C until required.
Cells were lysed by high-pressure disruption and insoluble debris was removed by centrifugation before purification of the protein from the crude lysate, as follows. Lysate was loaded onto a 5 mL Unosphere Q column (Bio-Rad, Hercules, CA, USA) and eluted using a linear NaCl gradient (20 to 700 mM). Fractions containing AfumPCNA were pooled and brought up to 1.5M (NH 4 ) 2 SO 4 by the dropwise addition of 3 M (NH 4 ) 2 SO 4 before incubating overnight at 4°C with gentle stirring. Precipitate was then cleared by centrifugation; supernatant was loaded onto a 5 mL HiTrap Phenyl FF column (GE) and eluted using a reverse linear salt gradient (1.5 to 0M (NH 4 ) 2 SO 4 , 20 to 0 mM NaCl). AfumPCNA fractions were pooled and dialyzed with 20 mM Tris pH 7.5, 50 mM NaCl, and 2 mM DTT overnight at 4°C. Dialyzed protein was concentrated to 10 mL and passed through a HiPrep Sephacryl 26/60 S-300 column (GE) equilibrated in 20 mM Tris pH 7.5, 50 mM NaCl, and 2 mM DTT. AfumPCNA fractions were then pooled and dialyzed against 20 mM Tris pH 7.5, 20 mM NaCl, and 2 mM DTT overnight at 4°C. Dialyzed protein was loaded onto a 1 mL Enrich Q column (Bio-Rad) and eluted using a linear NaCl gradient (20 to 500 mM). AfumPCNA fractions were pooled and dialyzed with 20 mM Tris pH 7.5, 2 mM DTT, and 10% glycerol overnight at 4°C, concentrated to approximately 10 mgÁmL À1 and subjected to crystallization trials immediately.
Crystallization, data collection, and structure determination
Protein crystallization was carried out by vapor diffusion in sitting-drop format at 16°C. Crystals grew as small plates in 0.2 M KCl, 20% PEG 3350, and diffracted X-rays to 2.6 A using the MX-1 beamline at the Australian Synchrotron [62] . Data were collected at 100 K using 1 o oscillations at a wavelength of 0.9537 A. The AfumPCNA data were processed in space group P2 1 using iMosflm and solved by molecular replacement using phaserMR [63] with a homology model built using chainsaw [23] . The Litopenaeus vannamei PCNA crystal structure (PDB: 4CS5) [64] was used as a template for the homology model. The structure was refined by iterations of manual rebuilding using Coot [65] and refinement using phenix.refine [66] . Groups for TLS parameterization [67] were defined automatically using phenix.refine and used for refinement as this improved refinement statistics. For the final rounds of refinement, NCS restraints were imposed along with optimization of X-ray/stereochemistry weight to improve the stereochemistry of the final model. The final rebuild was performed using a feature-enhanced map (FEM) generated using phenix [68] . The final structure contained 0.66% Ramachandran outliers with 99.34% of the residues contained in the most favored and allowed regions. Coordinates were deposited in the PDB, accession code 5TUP.
P21 peptide binding assay using fluorescence polarization
Fluorescence polarization assays were carried out on a PerkinElmer Victor X5 2030 Multilabel Reader, using 100 nM N-terminally FITC-labeled human P21 peptide (N-139 GRKRRQTSMTDFYHSKRRLIFS 160-C) as the labeled ligand, and increasing concentrations of AfumPCNA (0.2-26 lM). Experiments were performed at room temperature, in either buffer 1: 20 mM Tris (pH 7.5) with 10% glycerol, or buffer 2: phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO4, 8.1 mM Na 2 HPO 4 , pH 7.4). Each buffer also contained 2 mM DTT, 0.01% triton, 1 mM EDTA, and 1xCOMPLETE protease inhibitors.
Data were fit to the following equation:
where DFP is the measured change in fluorescence polarization, FP max is the maximum change in polarization of the labeled ligand upon saturation, L T is the ligand concentration, R T is the protein concentration, and K d is the dissociation constant for the interaction. Each experiment consisted of triplicate samples, and experiments were repeated three times to obtain a mean K d value, and standard deviation.
Molecular dynamics simulations
The p21 peptide was docked onto the AfumPCNA-binding surface of one subunit using the ICMPRO (Molsoft) software suite [69] . The trimeric complex of AfumPCNA-p21 was constructed using hPCNA as a guide after aligning individual AfumPCNA-p21 complexes with the hPCNA trimer. Molecular dynamics simulation of p21 peptide bound to the AfumPCNA was conducted using NAMD 2.9 [70] . PCNA and peptide complex was parameterized with the CHARMM27 force field [71] and solvated using the solvate plugin of VMD [72] . After neutralization, 150 mM NaCl was added to the solvated system using the autoionize plugin of VMD. Prior to the simulation, the system was equilibrated to NPT ensemble for a period of 2 ns. Then the production simulation was carried out for a period of 50 ns. During the simulation, a 12 A cutoff was used for nonbonded short-range interactions, and long-range electrostatics were treated with the particle-mesh Ewald method [73] . Temperature and pressure were maintained at 310K and 101.3 kPa using Langevin thermostat and the Langevin piston. The time step used was 1 fs. Trajectories were saved at every 20 ps. Data analysis and the visualization of the simulation were carried out by the VISUAL MOLECULAR DYNAMICS package [72] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53 
